Skip to main content
On Demand

Update in Cardiology


Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
State Associations:
OPSC - California
Faculty:
Christopher Wulff, MD
Duration:
1 Hour 01 Minutes
Expiration:
Never Expires.


Description

** Please note this program was featured in OPSC's 35th Annual Fall Conference, CME by the Bay 2024, held in Monterey, California. If you attended this event in person or purchased the digital edition, you will not qualify for CME credits by participating in the program. ** 

This lecture will be based on current state of the art cardiology treatments and guidelines.
 
Learning Objectives:
  • Identify current treatment options for coronary artery disease, atrial fibrillation, atrial flutter, PSVT and ventricular tachycardia.
  • Differentiate the difference between heart failure with preserved and reduced ejection fraction and the current guideline directed medical therapies.
  • Understand the available percutaneous options for the treatment of structural heart disease including aortic and mitral valve disease.
Disclosures: None Reported 
 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the AOA to provide osteopathic continuing medical education for physicians. 
 
Grievance Policy: Osteopathic Physicians and Surgeons of California (OPSC) strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at (916) 822-5246 or by email at opsc@opsc.org. 

Handouts

Faculty

Christopher Wulff, MD Related Seminars and Products


Pioneering alongside two of the original innovators of angioplasty in this country, Dr. Christoper Wulff gained advanced training in Interventional Cardiology at the San Francisco Heart institute. Recognized for his expertise in coronary and peripheral intervention and heart failure, he served as ValleyCare Medical Center’s first ever director, in Pleasanton, and established the Cardiac Catheterization Lab.

In addition to his commitment to the treatment of arterial vascular disease, Dr. Wulff established the first Bay Area Interventional Cardiology practice devoted to the treatment of venous disease, including endovascular ablation, sclerotherapy, and ambulatory microphlebectomy.


Reviews